send to a friend by email
2016-08-14
According to Jerusalem Pharmaceutical company financial statements for first half of 2016, Net profit after tax of the period reached 759,186 USD Compared with Net profit after tax 1,699,836 USD for 2015, a net decrease in profit of 55.34%.Total assets of the company reached 53,753,167 USD compared with total assets of 51,192,232 USD at the end of year 2015, a net increase of 5.00%.Total liabilities of the company reached 15,916,162 USD compared with total liabilities of 14,983,341 USD at the end of year 2015, a net increase of 6.22%. Net ownership equity of the company reached 37,837,005 USD (Including None-Controlling Interests of 541,427 USD) compared with total owner equity of 36,208,891 USD (Including None-Controlling Interests of 647,664 USD) at the end of year 2015, a net increase of 4.50%.Noting that paid-in capital increased from 17,060,000 USD in year 2015 to 18,000,000 USD of this year,a net increase of 5.51%.
|
|